BioSpace News Archive

Business

Invivyd Reports First Quarter 2023 Financial Results and Business Highlights

Invivyd, Inc., a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, announced financial results for the quarter ended March 31, 2023, and recent business highlights.

May 11, 2023
·
14 min read
Business

Ventyx Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress

Ventyx Biosciences, Inc. announced financial results for the first quarter ended March 31, 2023, and highlighted recent pipeline and business progress.

May 11, 2023
·
9 min read
Business

Hyperfine, Inc. Reports First Quarter 2023 Financial Results

Hyperfine, Inc., the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable, point-of-care MRI system, announced first quarter 2023 financial results and provided a business update.

May 11, 2023
·
10 min read
Business

Eyenovia Reports First Quarter 2023 Financial Results and Provides Business Update

Eyenovia, Inc. announced its financial and operating results for the first quarter ended March 31, 2023.

May 11, 2023
·
8 min read
Xenon Pharmaceuticals to Present at the 2023 RBC Capital Markets Global Healthcare Conference

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, announced that the company will present at the 2023 RBC Capital Markets Global Healthcare Conference taking place May 16-17, 2023 in New York, NY.

May 11, 2023
·
1 min read
Business

BioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress

BioAtla, Inc. announced its financial results for the first quarter ended March 31, 2023, and provided highlights on its clinical programs.

May 11, 2023
·
15 min read
Business

Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results

Talis Biomedical Corporation announced a business update and reported financial results for the first quarter ended March 31, 2023.

May 11, 2023
·
7 min read
Drug Development

Nkarta to Present NKX019 Phase 1 Dose Escalation Data at European Hematology Association 2023 Congress and 17th International Conference on Malignant Lymphoma

Nkarta, Inc. announced that it will present preliminary data from its Phase 1 dose escalation clinical trial of NKX019 at two upcoming scientific conferences in June 2023: the European Hematology Association 2023 Hybrid Congress and the 17th International Conference on Malignant Lymphoma.

May 11, 2023
·
4 min read
Business

Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update

Agile Therapeutics, Inc., a women’s healthcare company, reported financial results for the three months ended March 31, 2023 and provided a corporate update.

May 11, 2023
·
16 min read
Business

Sientra Reports Record First Quarter 2023 Operational Results

Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced its financial results for the first quarter that ended March 31, 2023.

May 11, 2023
·
17 min read